Biochemistry, Genetics and Molecular Biology
Lipid Droplet
100%
Perilipin
57%
Adipocyte
46%
Lipolysis
35%
Phosphodiesterase
28%
Genetic Divergence
28%
Lipoprotein
28%
Coat Protein
28%
Mitochondrion
25%
Insulin Resistance
23%
Lipid
21%
Homeostasis
20%
Metabolic Pathway
19%
Messenger RNA
19%
Peroxisome Proliferator-Activated Receptor
16%
Cardiac Muscle Cell
15%
EIF2AK3
14%
Bone Density
14%
Fibrinolysis
14%
Haplotype
14%
Gene Linkage
14%
Cholesterol Level
14%
Downregulation
14%
Protein Phosphorylation
14%
Toll-Like Receptor
14%
Endoplasmic Reticulum Stress
14%
HDAC3
14%
Gluconeogenesis
14%
Lipogenesis
14%
Long Non-Coding RNA
14%
Hormone-Sensitive Lipase
14%
Ginseng Extract
14%
Lipid Storage
10%
Triglyceride
10%
RNA
10%
Lipotoxicity
8%
Single-Nucleotide Polymorphism
8%
Adipose Differentiation-Related Protein
8%
Enzymatic Hydrolysis
8%
Prostaglandin E2
8%
interferon
8%
Lipid Homeostasis
7%
Surface Property
7%
Protein Family
7%
Cell Energy
7%
Insulin Sensitivity
7%
Signal Transduction
7%
Triacylglycerol Lipase
6%
Pancreatic Lipase
6%
Interferon
6%
Keyphrases
Rheumatoid Arthritis
42%
Peptidylarginine Deiminase 4
28%
Perilipin 5
28%
Lipid Droplets
28%
Arginine Deiminase
23%
Antilipolysis
18%
Autoantibodies
15%
Interstitial Lung Disease
14%
Heavy Chain
14%
PECAM-1
14%
Lipid Droplet Metabolism
14%
Rheumatoid Arthritis-associated Interstitial Lung Disease
14%
Constant Region
14%
Overexpression
14%
Genetic Variation
14%
Serum Antibody
14%
Endothelial Dysfunction
14%
Systemic Lupus Erythematosus
14%
Human Myoblasts
14%
Energy Homeostasis
14%
Myocardial Steatosis
14%
Specific Lipids
14%
Toll-like
14%
Cardiac Dysfunction
14%
Disease Subsets
14%
Sex-specific
14%
Rat Adipocytes
14%
Lung Fibrosis
14%
Annexin A2 (ANXA2)
14%
X-inactive Specific Transcript
14%
Severe Disease
14%
Cardiomyocytes
14%
Lipid Droplet-associated Proteins
14%
Improved Survival
14%
Malnourished Mice
14%
Post-treatment Lyme Disease Syndrome (PTLDS)
14%
Long Non-coding RNA (LncRNA)
14%
Whole-body
14%
MRNA Expression
14%
Phosphodiesterase-4 (PDE4)
14%
Deiminase
14%
Body Energy
14%
Rheumatoid Arthritis Patients
14%
Rs3798220
10%
Anti-PAD4
9%
Lipid Storage
9%
Healthy Controls
9%
Anti-annexin A2 Antibodies
8%
Anti-citrullinated Protein Antibodies
8%
Joint Disease
8%
Immunology and Microbiology
Monospecific Antibody
62%
Inflammatory Arthritis
56%
Autoantibodies
31%
Genetic Variability
28%
Kringle Domain
14%
Antibody Blood Level
14%
Toll-Like Receptor
14%
Capping Phenomenon
14%
Fibrinolysis
14%
Platelet
14%
Genetic Variation
14%
Heavy Chain
14%
Cholesterol Level
14%
Systemic Lupus Erythematosus
14%
interferon
8%
Methotrexate
7%
Immunoglobulin G1
7%
Immunoglobulin G3
5%